Privia Health renews Anthem deal. Target for Privia Health stock is USD 31.00

Published on 10/16/2026 at 01:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue rose 21.40 percent to USD 632.63 million. Consensus target for Privia Health stock is USD 31.00 on October 15, 2026.

Network expansion and earnings dates

Privia renewed its Anthem agreement in Virginia on October 14, 2026, preserving in-network access.
Second-quarter revenue reached USD 632.63 million, up 21.40 percent year over year.
Privia will report third-quarter 2026 results on November 5, 2026.

PRVA, US74276R1023, Illustration mit AI erstellt.

Privia Health Group (ISIN US74276R1023) renewed its Anthem agreement in Virginia on October 14, 2026, while its network covered 5,644 implemented providers across 25 states and Washington, D.C., according to Simply Wall St. The company had already delivered USD 632.63 million in second-quarter revenue, up 21.40 percent year over year, as Benzinga reported.

Anthem renewal adds network scale

The renewed Virginia agreement keeps Privia Medical Group physicians in network for Anthem members across the state. That matters because Privia's operating model depends on combining physician support, payer relationships and value-based care programs.

The network reached 5,644 implemented providers by June 30, 2026, and served more than 6.1 million patients across 25 states and Washington, D.C. The scale figure came from the second-quarter earnings call, which also described provider retention averaging 98 percent over the past three years, according to Benzinga.

What does the margin mean?

Privia's second-quarter adjusted EBITDA rose 29.00 percent year over year to USD 37.40 million, while adjusted EBITDA reached 28.30 percent of care margin. For the first half of 2026, adjusted EBITDA increased 32.50 percent to USD 74.10 million, giving the company room to raise its outlook across key metrics.

The main operating counterweight is cash timing. Management said 70.00 to 80.00 percent of full-year adjusted EBITDA should convert to free cash flow, while shared-savings settlements may arrive later than usual. MarketBeat's October 15, 2026 report cited 11 Buy ratings, three Holds and a USD 31.00 consensus target for Privia Health stock, linking the valuation debate to continued execution.

Three dated steps for Privia

On May 27, 2026, Privia signed its New Jersey partnership and extended its footprint to a 25th state, according to Simplify Jobs. On August 6, 2026, second-quarter revenue reached USD 632.63 million and adjusted EBITDA grew 29.00 percent, according to Benzinga.

On October 14, 2026, the Anthem renewal kept Virginia physicians in network, with the broader platform spanning 5,644 implemented providers, according to Simply Wall St.

Next reporting date

Privia is scheduled to report third-quarter 2026 results on November 5, 2026, according to the company's investor-relations page. The release date gives investors a defined checkpoint for revenue growth, provider additions and cash conversion.

Valuation stays tied to execution

MarketBeat reported a market capitalization of USD 2.77 billion, a one-year range of USD 18.92 to USD 28.82 and a consensus target of USD 31.00 on October 15, 2026. Those figures frame the next results around operating delivery rather than the Anthem agreement alone.